Kurtoxin

Lys-Ile-Asp-Gly-Tyr-Pro-Val-Asp-Tyr-Trp-Asn-Cys-Lys-Arg-Ile-Cys-Trp-Tyr-Asn-Asn-Lys-Tyr-Cys-Asn-Asp-Leu-Cys-Lys-Gly-Leu-Lys-Ala-Asp-Ser-Gly-Tyr-Cys-Trp-Gly-Trp-Thr-Leu-Ser-Cys-Tyr-Cys-Gln-Gly-Leu-Pro-Asp-Asn-Ala-Arg-Ile-Lys-Arg-Ser-Gly-Arg-Cys-Arg-Ala (Disulfide bonds between Cys¹²-Cys⁶¹, Cys¹⁶-Cys³⁷, Cys²³-Cys⁴⁴, and Cys²⁷-Cys⁴⁶)
: (M.W. 7386.4) C₃₂₄H₄₇₈N₉₄O₉₀S₈
: T-type Ca²⁺ Channel Blocker

Package	Price(Yen)	Availability	Quantity
Vial 0.1 mg	30,000	Ships within 1-3 business days
バルク見積もり

Solubility: H₂O (50 μM)

R.S-I. Chuang, H. Jaffe, L. Cribbs, E. Perez-Reyes, and K.J. Swartz, Nat. Neurosci., 1, 668 (1998). (Original)
S.S. Sidach and I.M. Mintz, J. Neurosci., 22, 2023 (2002). (Pharmacol; Specificity for Ca2+-Channel Blocking Activity)
T. Olamendi-Portugal, B.I. García, I. López-González, J. Van DerWalt, K. Dyason, C. Ulens, J. Tytgat, R. Felix, A. Darszon, and L.D. Possani, Biochem. Biophys. Res. Commun., 299, 562 (2002). (Pharmacol.)
I. López-González, T. Olamendi-Portugal, J.L. De La Vega-Beltrán, J. Van derWalt, K. Dyason, L.D. Possani, R. Felix, and A. Darszon, Biochem. Biophys. Res. Commun., 300, 408 (2003). (Pharmacol.)
H. Nishio, Y. Nishiuchi,M. Is himaru, and T. Kimura, Lett. Pept. Sci., 10, 589 (2003). (Chem. Synthesis & S-S Bond)